OliX says its expansion will include the construction of an RNA synthesis GMP manufacturing facility at its San Diego site, which will initially carry out oligonucleotide chemistry and analysis for investigational therapeutics to be developed in-house for clinical testing, with the potential to manufacture commercial RNAi therapeutics there . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge